Chesterfield, MO, United States of America

Dennis Patrick Riley

USPTO Granted Patents = 55 

 

 

Average Co-Inventor Count = 2.8

ph-index = 13

Forward Citations = 665(Granted Patents)

Forward Citations (Not Self Cited) = 426(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Ballwin, MO (US) (1990 - 2003)
  • Conneaut Lake, PA (US) (2009)
  • St. Louis, MO (US) (1989 - 2016)
  • Chesterfield, MO (US) (1989 - 2024)

Company Filing History:


Years Active: 1989-2025

Loading Chart...
Loading Chart...
Loading Chart...
55 patents (USPTO):Explore Patents

Title: Dennis Patrick Riley: A Pioneering Innovator in Disease Treatment

Introduction:

In the world of patents and inventions, Dennis Patrick Riley has emerged as a prominent figure, with his groundbreaking contributions to the field of disease treatment. With a remarkable portfolio of 52 patents, Riley's innovative methods have pushed the boundaries of medical science. This article explores some of his latest patents, career highlights, and notable collaborations.

Latest Patents:

Riley's latest patents showcase his dedication to finding novel methods for the treatment of various diseases. Two notable examples include:

1. Methods for treatment of diseases:

Riley's innovative methods aim to treat a range of diseases or conditions by administering a superoxide dismutase mimetic. This approach presents a promising avenue for combating various ailments, demonstrating Riley's commitment to advancing medical treatment options.

2. Combination cancer immunotherapy with pentaaza macrocyclic ring complex:

In this patent, Riley presents a method for treating cancer using a combination therapy approach. By administering an immune checkpoint inhibitor and a pentaaza macrocyclic ring complex, the response of the cancer to the immune checkpoint inhibitor is enhanced. This innovation holds great potential for improving cancer treatment outcomes.

Career Highlights:

Riley's illustrious career has seen him contribute to renowned companies in the field of scientific research. Notably, he has worked at Monsanto Corporation and Galera Labs, LLC. These organizations provide a platform for brilliant minds like Riley to thrive and bring their scientific expertise to life. Through his work, Riley has consistently demonstrated a commitment to pushing the boundaries of medical innovation.

Collaborations:

In his quest for scientific advancements, Riley has collaborated with esteemed colleagues, some of whom include Jeffery L Keene and Patrick J Lennon. These collaborations leverage the collective expertise of accomplished professionals, fostering an environment of innovation and collaboration. Together, they strive to tackle complex challenges in disease treatment and bring forth groundbreaking solutions.

Conclusion:

Dennis Patrick Riley's remarkable contributions to the field of disease treatment have solidified his place as an innovator and inventor. With an impressive portfolio of patents, Riley's methods have the potential to shape the future of medical science. Through his career at esteemed companies like Monsanto Corporation and Galera Labs, LLC, Riley's expertise has found a platform to make a lasting impact. With ongoing collaborations with colleagues such as Jeffery L Keene and Patrick J Lennon, Riley continues to explore new avenues for advancements in disease treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…